Technology
SOCOTEC USA PROUDLY ACHIEVES PRESTIGIOUS GREAT PLACE TO WORK® CERTIFICATION
Published
4 months agoon
By
NEW YORK, July 18, 2024 /PRNewswire/ — SOCOTEC USA, a leading provider of TIC (Testing, Inspection, and Certification), consulting, and advisory services with a strategic focus on buildings and infrastructure, is proud to announce that it has been officially certified as a Great Place to Work by the renowned global authority on workplace culture, Great Place to Work®.
The Great Place to Work Certification recognizes companies that build a high-trust, high-performance culture and consistently strive to maintain and further improve this for the benefit of their employees. This year, SOCOTEC USA excelled in all five key areas of measure: credibility, respect, fairness, pride, and camaraderie. Overall, an impressive 77% of survey participants considered SOCOTEC USA a Great Place to Work, surpassing the 65% Trust Index required to be certified as a “World Best Workplace.”
“We are thrilled to achieve this certification, which is a testament to our commitment to fostering a supportive and professional environment where our employees can grow and develop their expertise,” said CEO of SOCOTEC USA, Nicolas Detchepare. “Our aim is to be the most desirable company in our industry, offering limitless opportunities for our employees.”
Key Highlights of Our Certification:
Safety: SOCOTEC USA achieved an outstanding 96% positive rating in workplace safety, a best-in-class result. The company will continue to prioritize safety through initiatives like SOCOTEC’s Safety Week and regular training for employees.Justice: The company’s results in the ‘Justice’ section of the survey were on par with the ‘World’s Best Workplaces’ with 91% of employees feeling that they are treated fairly regardless of their age, ethnicity, gender, or sexual orientation. SOCOTEC is a proud Equal Opportunity Employer, showcasing its inclusive approach to talent across all parts of society.Pride: The results gathered from SOCOTEC USA’s employees demonstrated a nearly 80% sense of pride in the workplace. Employees are proud of the work they do and are proud to tell others about it – a shared sentiment of our customers who echo our services as “excellent.”
Looking to the future, SOCOTEC aims to not only strengthen its position as the industry’s most attractive company but also to create an environment where every team member feels valued and proud to be part of the journey. Its mission is to continue to build on the achievements and ensure a positive, supportive workplace for all.
About SOCOTEC
The SOCOTEC Group, headed by Hervé Montjotin, has built its reputation as an independent, trusted partner assisting companies in the areas of quality, sustainability and safety, and the environment.
Today a leading $1.3 billion EUR company that more than doubled in size in 6 years, SOCOTEC’s mission is to ensure the integrity and performance of building and infrastructure assets and people’s safety. Through its inspection and measurement, assistance and consultancy, training, and certification services, SOCOTEC helps to optimize the performance of companies in every sector by managing the risks inherent in their activities. Drawing on its expertise and positioning itself as a long-term partner, SOCOTEC supports its clients throughout their project’s lifecycle.
As a major player in TIC for the building and infrastructure sectors, the SOCOTEC Group has 200,000 clients with operations in 26 countries, 12,000 employees and over 250 external recognitions.
SOCOTEC, an industry leader in the building and infrastructure sectors, offers the combined highly technical expertise of an expansive and holistic network of experts across nine service lines: (i) Building Envelope; (ii) Energy & Sustainability; (iii) Code & Planning; (iv) Life Safety; (v) Project Advisory; (vi) Dispute Resolution; (vii) Specialty Engineering; (viii) Testing; and (ix) Special & Progress Inspection. In the USA, SOCOTEC employs over 650 professionals in more than 25 offices.
Visit www.socotec.us for more information.
View original content to download multimedia:https://www.prnewswire.com/news-releases/socotec-usa-proudly-achieves-prestigious-great-place-to-work-certification-302199982.html
SOURCE SOCOTEC
You may like
Technology
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™
Published
19 mins agoon
November 12, 2024By
DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ — The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 billion in 2024, at a CAGR of 29.9% from 2024 to 2029. The rising shift towards integrating AI for understanding diseases and small molecule design and optimization use cases augments the growth of the market. AI tools play a major role in accelerating target identification, optimizing lead compound selection, and predicting drug efficacy and toxicity. Supervised methods such as regression, decision trees, and neural networks help predict material properties and drug candidate profiles. In contrast, unsupervised techniques such as clustering algorithms (k-means and hierarchical clustering) and dimensionality reduction identify hidden trends, patterns, and groupings in data, aiding in novel drug discovery. Deep Learning is employed to predict molecular properties, design new compounds, and other applications. Convolutional Neural Networks (CNNs) and Recurrent Neural Networks (RNNs) are more commonly used for handling complex data, such as sequences or molecular structures. Generative Adversarial Networks (GANs) are utilized to generate de novo or novel drug candidates, molecular structure simulation, and lead optimization. These tools help streamline processes, as well as reduce the time and cost involved in screening, optimizing, and discovering new drug candidates.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151193446
Browse in-depth TOC on “Artificial Intelligence in Drug Discovery Market”
270 – Tables
50 – Figures
350 – Pages
Based on therapeutic area, the artificial intelligence (AI) in drug discovery market is segmented into oncology, infectious diseases, neurology, metabolic diseases, cardiovascular diseases, immunology, mental health, and others (respiratory diseases, nephrology, dermatological diseases, genetic disorders, inflammatory diseases, and gastrointestinal). The neurology segment held the fastest market share in the Al drug discovery market due to the increasing number of neurological disorders and the difficulties associated with drug discovery in this field, The use of Al technologies accelerates drug development because neurological diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis are difficult to diagnose and treat.
According to the WHO, in 2021, neurological conditions affected over 3 billion people worldwide. This emphasizes the need for innovative healthcare solutions. Al-powered drug discovery platforms work well in neurology, allowing faster and more accurate analysis of complex neurological data to identify potential drug candidates. The increasing availability of large datasets from clinical trials, genomics, neuroimaging, and electronic health records (EHR) records, as well as the growth investments in neurology, also contribute to market growth. In 2023, venture investments in neurology companies were USD 1.14 billion in the US. Resources like the Alzheimer’s Disease Neuroimaging Initiative (ADNI) provide vast data for machine learning applications.
Based on the process, artificial intelligence (AI) in drug discovery market is broadly classified into target identification & selection, target validation, hit identification & prioritization, hit-to-lead identification/lead generation, lead optimization, and candidate selection & validation. Hit-to-lead identification/lead generation accounts for the largest process segment in this market; it is also expected to register the highest growth owing to its critical role in streamlining the early stages of the drug development process. AI can significantly reduce the number of compounds and experiments required to find and optimize leads. This procedure uses Al algorithms to analyse large datasets, such as chemical libraries and biological interactions, to identify potential drug candidates or hits and develop them into viable leads. AI helps address long design-make-test cycles across discovery journeys. Faster screening and better exploration of vast chemical libraries are fuelling market growth for AI solutions for hit-to-lead identification/lead generation. For example, activity prediction enables more targeted experiments, and predictive analytics can help forecast compound properties. However, the lack of existing clinical data for a new molecule can hinder market growth.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=151193446
There are several opportunities in AI in drug discovery market such as growing biotech industry, emerging markets, AI in single cell experiments, Growing demand for precision medicine and personalized medicine. Key players in the artificial intelligence (AI) in drug discovery are NVIDIA Corporation (US), Exscientia (UK), Google (US), BenevolentAI (UK), Recursion (US), Insilico Medicine (US), Schrödinger, Inc. (US), Microsoft (US), Atomwise Inc. (US), Illumina, Inc. (US), Valo Health (US) among others. These players not only have a comprehensive and diverse product portfolio but also a strong geographic presence.
The key players in this market can tap these opportunities to enhance and improve their product offerings and develop innovative AI solutions for various processes, use cases, and end users. Moreover, these companies can integrate AI in drug design and optimization, understanding diseases, drug repurposing, single-cell analysis, and identification of biomarkers, disease types, and subtypes. Additionally, key players invest in AI algorithms that can examine complicated data and interpret disease mechanisms and pathways. Collaborations and partnerships between key players continue to grow rapidly, which in turn has accelerated the development of targeted therapies and contributed to rapidly expanding drug pipelines.
These market players have offered a diverse range of products and services and have operations worldwide with a major focus on North America. They rely on technological advancements to avail themselves of innovative end-to-end solutions, software, and services and increase their global footprint. These players focus on product launches and enhancements, investments, partnerships, collaborations, agreements, joint ventures, funding, acquisitions, expansions, conferences, FDA clearances, sales contracts, alliances, and other recent developments to expand their global reach and develop AI in drug discovery solutions.
NVIDIA Corporation:
NVIDIA Corporation, a prominent technology company, has made remarkable advances in artificial intelligence (AI), particularly drug discovery. NVIDIA GPUs power AI workloads in drug discovery applications such as molecular modeling, simulation, and machine learning. Nvidia’s AI software includes development tools, libraries, and frameworks that can be used to build and deploy AI applications for drug discovery. The company provides generative AI platforms like BioNeMo and Clara Discovery. NVIDIA BioNeMo simplifies the deployment of AI models, hastening the transition to AI-driven drug discovery. It offers models for 3D protein structure prediction, molecule generation, property predictions, and molecular docking. Users can customize AI models with their data, access pre-trained models, and integrate them into drug discovery workflows. NVIDIA Clara Discovery is a software suite that includes a variety of tools for AI-driven drug discovery.
NVIDIA Corporation operates more than 50 offices across the Americas, Asia, and Europe, along with manufacturing facilities in the US and Taiwan. The company collaborates with several pharmaceutical companies and biotech startups to develop solutions for AI-driven drug discovery. For example, in November 2023, NVIDIA collaborated with Genentech to improve computational models and incorporate generative AI into drug discovery processes, allowing for faster exploration of molecular designs.
Insilico Medicine:
Insilico Medicine is an end-to-end generative AI-driven biotech company accelerating drug discovery and development to treat cancer and age-related diseases. Its proprietary Pharma.AI platform spans biology, chemistry, and clinical development. The company pioneered the application of reinforcement learning and generative adversarial networks (GANs) to develop new molecular structures for diseases with known and unknown targets. Its products and services are used by pharmaceutical companies, biotechnology companies, and academic research institutions. Insilico Medicine has produced a diversified internal pipeline of 31 programs for 29 drug targets. The company’s lead drug is ISM001-055, a small-molecule chemical drug candidate primarily designed to treat fibrosis-related indications, including idiopathic pulmonary fibrosis. The company has offices in the US, Hong Kong, Canada, and the UAE. The company has more than 150 academic and industrial collaborations worldwide. For instance, in September 2024, Insilico Medicine collaborated with Inimmune to leverage its proprietary AI platform, Chemistry42, in accelerating the discovery and development of next generation immunotherapeutic.
Exscientia:
Exscientia is an AI-driven small-molecule drug discovery and design company. The company designed and developed an end-to-end solution of AI and experimental technologies for target identification, drug candidate design, translational models, and patient selection. The company’s patient-first AI process comprises four elements, namely, Precision Target (experimental and literature-based AI systems to prioritize projects), Precision Design (an extensive platform of AI technologies to design innovative drugs), Precision Experiment (tech-enabled precision experimentation to derive better data), and Precision Medicine (integrated analysis of patient data to ensure clinical relevance). The platform has helped design candidate drug molecules that have progressed into clinical trials and improve disease understanding through AI-guided assessment and generative AI. Exscientia collaborates with pharmaceutical companies such as GSK, Sanofi, and Roche. The company has offices in the UK, the US, and Japan. For instance, in July 2024, Exscientia announced the expansion of its collaboration with Amazon Web Services, Inc. to utilize AWS’s AI and machine learning services, further enhancing its end-to-end drug discovery and automation platform.
For more information, Inquire Now!
Related Reports:
Get access to the latest updates on Artificial Intelligence in Drug Discovery Companies and Artificial Intelligence in Drug Discovery Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/artificial-intelligence-in-drug-discovery-market-to-hit-usd-6-89-billion-by-2029-with-29-9-cagr–marketsandmarkets-302302221.html
Technology
Mainframe Modernization Services Market Skyrockets to $86.14 Billion by 2031 Dominated by Tech Giants – Accenture, Capgemini and Cognizant | The Insight Partners
Published
19 mins agoon
November 12, 2024By
The global mainframe modernization services market is set for explosive growth, with projections indicating a surge to $86.14 billion by 2031. This remarkable expansion, driven by rising adoption of mainframe modernization services and increasing digital transformation across the globe.
NEW YORK, Nov. 12, 2024 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, “Mainframe Modernization Services Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Services (Application Modernization, Cloud Migration, and Data Modernization), Enterprise Size (Large Enterprises and SMEs), End-Use Industry (IT and Telecom, BFSI, Healthcare, Manufacturing, Retail, Education, and Others), and Geography”.
For Detailed Market Insights, Visit: https://www.theinsightpartners.com/reports/mainframe-modernization-services-market
The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the mainframe modernization services market comprises a vast array of services enterprise size, end users and geography which are expected to register strength during the coming years.
For More Information and To Stay Updated on The Latest Developments in The Mainframe Modernization Services Market, Download The Sample Pages: https://www.theinsightpartners.com/sample/TIPRE00028613/
Market Overview and Growth Trajectory:
Mainframe Modernization Services Market Growth: According to an exhaustive report by The Insight Partners, the Mainframe Modernization Services Market is experiencing significant growth, driven by digital transformation across the globe and growing adoption of cloud computing. The market, valued at $33.55 billion in 2023, is expected to grow at a Compound Annual Growth Rate (CAGR) of 12.5% during 2023–2031.
Technological Innovations: The integration of AI and machine learning is emerging as a key trend in the mainframe modernization services market, transforming how organizations approach legacy system modernization. Mainframe users nowadays are searching for ways to leverage AI and machine learning to enhance availability and performance, proactively detect problems, and accelerate application releases and DevOps procedures. Artificial intelligence, generative AI and machine learning can help accelerate mainframe modernization services. AI and ML technologies can analyze vast amounts of legacy code and data, helping to streamline the modernization process. These tools can automatically identify dependencies, assess code quality, and even suggest optimization strategies. This not only accelerates the modernization timeline but also reduces the risk of errors that can occur during manual code analysis.
The Rise in Adoption of Mainframe Modernization Services in Various Sectors: The IT and telecom sector experienced significant growth with the integration of emerging technologies such as the Internet of Things (IoT), automation, machine learning, and artificial intelligence (AI). Technologically advanced companies are prioritizing mainframe modernization services for the efficient operation of the systems. The mainframe modernization services help in migrating the mainframe applications to the cloud applications using API, microservices, and DevOps. Mainframe systems combine high-performance hardware, software tools, and large individual programmed applications that need modernization services for efficient operation.
Stay Updated on The Latest Mainframe Modernization Services Market Trends: https://www.theinsightpartners.com/sample/TIPRE00028613/
Digital Transformation Across the Globe: Digital technologies are transforming communications, business, health, education, finance, etc. The COVID-19 pandemic increased the adoption of digital technologies and enhanced productivity. Digitization saved many companies during the pandemic by adapting to remote work cultures and online operations. Developing economies such as India, China, South Africa, Brazil, and Argentina are adopting advanced digital technologies in various sectors, such as healthcare, manufacturing, energy and power, and IT & telecom, to enhance productivity and economic growth. For instance, the Digital India initiatives launched by the Indian government improved the online infrastructure and increased internet accessibility in most of the rural areas. According to Cisco, by 2024, around 75% of start-ups in Canada will have a digital-first strategy. Moreover, over 50% of SMEs re-organized their company structure in Canada. Such rising adoptions of digital technologies have increased the demand for robust IT infrastructure and are driving the mainframe modernization services market.
Geographical Insights: North America dominated the mainframe modernization services market in 2023. Europe is the second-largest contributor to the global mainframe modernization services market, followed by Asia Pacific.
Mainframe Modernization Services Market Segmentation, Applications, Geographical Insights:
Based on services, the mainframe modernization services market is segmented into application modernization, cloud migration, and data modernization. The application modernization segment dominated the market in 2023.By enterprise size, the market is bifurcated into SMEs and large enterprises. The large enterprises segment dominated the market in 2023.In terms of end-use industry, the market is segmented into IT and telecom, BFSI, retail, healthcare, government, media and entertainment, manufacturing, education, and others. The IT and telecom segment held the largest market share in 2023.The mainframe modernization services market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America.
Purchase Premium Copy of Global Mainframe Modernization Services Market Size and Growth Report (2023-2031) at: https://www.theinsightpartners.com/buy/TIPRE00028613/
Key Players and Competitive Landscape:
The Mainframe Modernization Services Market is characterized by the presence of several major players, including:
AccentureCapgeminiCognizantAmazon Web Services, Inc.Infosys LimitedFujitsuHCL Technologies LimitedWipro DigitalIBMEnsonoTata Consultancy Services LimitedAtos SEHexaware Technologies LimitedMicrosoftDXC Technology CompanyEPAM Systems, Inc.Innova SolutionsOracle; MphasisSoftware AG
These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market.
Mainframe Modernization Services Market Recent Developments and Innovations:
‘Accenture Federal Services had been awarded the US Army’s Enterprise Application Modernization and Migration (EAMM) contract with a potential value of US$ 127 million. Accenture Federal Services will use its cloud migration and modernization approach to perform large-scale application assessments, migrations, and modernizations to the cloud.”Fujitsu announced the Japan market launch of its successful modernization automation service ‘Fujitsu PROGRESSION,’ building on a proven track of over 50 global use cases in which it migrated legacy systems to the Fujitsu mainframe ‘GS21 Series.’ ‘Fujitsu PROGRESSION’ is a service that automatically converts script written in COBOL into Java or C# while preserving the functionality of applications built on mainframes. It delivers modernization services for end-to-end support, from drafting migration plans based on customer systems audits to asset migration through to testing and operation.’
For Region-Specific Market Data, Check Out Brief Sample Pages: https://www.theinsightpartners.com/sample/TIPRE00028613/
Mainframe Modernization Services Market Drivers, Challenges, Future Outlook and Opportunities:
In terms of revenue, North America dominated the mainframe modernization services market share, followed by Europe and APAC. According to the International Trade Administration, the US accounts for one-third of the US$ 5 trillion worldwide information technology (IT) market, making it the world’s largest. In addition, the IT sector supports the employment of 12.1 million people and contributes ~US$ 1.9 trillion to the US value-added GDP. Furthermore, according to CompTIA, there are over 557,000 software and IT service companies in the US. As per the International Trade Administration, the ICT industry in Canada comprises more than 43,200 businesses. The majority of these companies operate in the computer services and software sectors. The industry is primarily made up of small businesses, with ~35,500 employing fewer than ten people. There are nearly 100 significant companies, including subsidiaries of international multinational corporations, that employ more than 500 people. Having such a big IT industry in the region is raising the need for mainframe modernization services. According to the Canada Health Infoway, Canadians are embracing digital health services, and it is also estimated that the demand for digital healthcare services will increase in the coming year. According to an online survey conducted in November 2022 with 12,445 Canadians, 94% of Canadians were interested in accessing digital health services. Thus, growing digitization in the healthcare sector is projected to raise the need for mainframe modernization services.
Cloud computing adoption is a strategic move by companies to reduce costs, mitigate risks, and achieve scalability of database functions. Industries such as healthcare, marketing & advertising, retail, finance, and education are highly benefitted from the adoption of cloud computing. For instance, due to digital and social consumer behavior and the rising demand for accessible and secure electronic health records (EHRs), hospitals, clinics, and other medical institutions are increasingly utilizing cloud computing for document storage, marketing, and human resources management. In addition, efficient expense management, human resources, and customer communications are the key business needs of financial organizations, driving the need for cloud computing for placing their email platforms and marketing tools on the cloud. According to the Flexera 2022 State of the Cloud Report, the Americas has 63% heavy cloud users, 23% moderate cloud users, and 14% light cloud users.
For In-Depth Market Forecasts and Analysis, Request PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00028613/
Modernized mainframe systems seamlessly integrate with other systems, applications, and data sources, enabling the creation of new business models and revenue streams. Additionally, modernization helps companies address the challenges of an aging workforce, reduce maintenance and operational costs, and improve system performance and scalability. In December 2022, AWS partnered with IBM to drive the mainframe modernization. Through this partnership, organizations bridge the gap by leveraging a hybrid strategy (e.g., mainframe modernization), integrating on-premises mainframe with cloud development, and beginning to leverage the scalability and agility benefits of cloud computing.
Conclusion:
The concept of modernization has expanded as companies explore different approaches to deliver robust enterprise-level IT services, from interface and platform updates to data management and language innovation. This trend toward more comprehensive modernization strategies has recently gained momentum. Over the past year, both new and established players have consolidated their presence in this market, indicating the potential of this space for significant returns. The movement among providers represents a decisive and positive change and promotes healthy debate within the industry.
Key factors driving the growth of the mainframe modernization services market include the rise in the adoption of mainframe modernization services in various sectors, digital transformation across the globe, and the growing adoption of cloud computing. However, challenges faced by IT companies in mainframe modernization are the key restraints in the market. Nevertheless, the growth of the data analytics industry across the globe is expected to create opportunities for the key players operating in the mainframe modernization services market. Furthermore, an increase in investment toward the transformation of IT infrastructure to provide efficient operation and services to consumers is expected to be the key future trend in the mainframe modernization services market from 2023 to 2031.
Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: https://www.theinsightpartners.com/inquiry/TIPRE00028613/
With projected growth to $86.14 billion by 2031, the Mainframe Modernization Services Market represents a significant opportunity for software and services providers, system integrators, investors, industry stakeholders and end users. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape.
Related Report Titles:
Application Modernization Services Market Size and Forecasts (2021 – 2031)Application Modernization Tools Market to Reach US$ 36.86 Bn at a CAGR of 18.7% in 2027Cloud Migration Services Market Statistics Report – Size, Share & Forecast 2030Cloud Migration Market Size and Forecasts (2021 – 2031)Cloud Computing Services Market Size and Forecasts (2021 – 2031)Cloud Computing Market Share, Size and Trends| 2028Artificial Intelligence Market Size and Forecasts (2021 – 2031)
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/mainframe-modernization-services-market
Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg
Technology
Zymo Research Fights Back Against Qiagen’s Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation
Published
19 mins agoon
November 12, 2024By
IRVINE, Calif., Nov. 12, 2024 /CNW/ — Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of California against Qiagen GmbH (Qiagen) alleging that Qiagen has engaged in antitrust violations and improperly interfered with Zymo Research’s contractual relations. These claims were filed as part of an amended response to a patent infringement lawsuit previously filed by Qiagen. In addition to asserting its claims for antitrust and interference, Zymo Research’s amended response denies all of Qiagen’s allegations of infringement.
Zymo Research believes that Qiagen’s lawsuit is part of a larger strategy to misuse litigation as a tool to stifle innovation and delay the adoption of groundbreaking technologies that benefit the scientific and medical communities. By bringing its counterclaims, Zymo Research not only intends to vindicate its position in the lawsuit against Qiagen, but to shed light on the misuse of litigation as a weapon against technological progress.
“Qiagen’s lawsuit was not brought in good faith and lacks merit. The scientific community deserves access to cutting-edge tools that foster growth and discovery, and we are committed to defending our breakthrough cfDNA technology and our contributions to the scientific community.” said Dr. Marc Van Eden, VP of Corporate Development.
About Zymo Research Corporation
Zymo Research, a private biotech company established in 1994 and headquartered in Irvine, California, is a global leader in innovative molecular tools for life sciences. Driven by the principle “The Beauty of Science is to Make Things Simple,” Zymo Research is dedicated to developing reliable solutions that address complex scientific challenges. Known also as The Epigenetics Company, Zymo Research offers a comprehensive range of technologies, including solutions for sample collection, DNA/RNA purification, NGS library preparation, microbiomics, transcriptomics, epigenomics, genomics, and Next-Generation Sequencing (NGS) services.
Through scientific innovation, Zymo Research is committed to engineering sustainable biotech solutions that fundamentally change how life science research is conducted– as demonstrated by their ambient temperature sample collection and transportation DNA/RNA Shield system, which eliminate cold chain logistics completely, thus reducing waste and the environmental footprint.
For more information visit www.zymoresearch.com
Note to Editors: Zymo Research’s counterclaims in the legal proceedings allege that Qiagen’s actions violate antitrust principles and interfere with Zymo Research’s business relationships.
View original content to download multimedia:https://www.prnewswire.com/news-releases/zymo-research-fights-back-against-qiagens-lawsuit-asserts-antitrust-violations-and-attempts-to-stifle-innovation-302302850.html
SOURCE Zymo Research Corp.
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™
Mainframe Modernization Services Market Skyrockets to $86.14 Billion by 2031 Dominated by Tech Giants – Accenture, Capgemini and Cognizant | The Insight Partners
Zymo Research Fights Back Against Qiagen’s Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days ago
MaidCentral Partners with Maid Brigade to Empower Franchise-Wide Efficiency and Customer Satisfaction for the House Cleaning Industry
-
Technology4 days ago
Bulletin from the Extraordinary General Meeting in Sivers Semiconductors AB (publ) on 8 November 2024
-
Coin Market4 days ago
Lack of blockchain literacy feeds lawmaker apprehension — Lee Bratcher
-
Technology5 days ago
Tucows Reports Financial Results for Third Quarter 2024
-
Technology5 days ago
Ecobank Partners with Nium to Unlock Real-Time Cross-Border Payments Across 35 African Markets
-
Technology4 days ago
WiMi Researches Reinforcement Learning-Based Blockchain Federated Learning Framework to Optimize Model Aggregation Strategy and Security
-
Technology4 days ago
Flight Data Monitoring Market Surges to USD 16.6 Billion by 2030, Propelled by 11.8% CAGR – Verified Market Reports®
-
Technology4 days ago
Sparrow BioAcoustics and Killick Capital host launch event for Canada’s First Cardiac AI Application – Stethophone